Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2003
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195200 Compounds, their preparation and use
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/16/2003CA2481916A1 A therapeutic agent for impaired gastric accommodation
10/16/2003CA2478227A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/15/2003EP1352908A1 Method of producing optically active lactone compound and complex used in the method
10/15/2003EP1352904A1 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns
10/15/2003EP1352901A2 Process for the preparation of cyclic diketones
10/15/2003EP1352687A1 Preparation of new layered double hydroxides exchanged with diisopropylamide for c-c bond forming reaction
10/15/2003EP1352653A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351949A1 Continuous process for producing l-ascorbic acid
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351915A2 Addition of mineral acids or salts thereof to a trimellitic acid anhydride production process
10/15/2003EP1351907A1 2-butyl-3-(4- 3(dibutylamino)propoxy benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof
10/15/2003EP1351763A1 Catalytic coating for the hydrogenation of maleic anhydride and related compounds to give gamma-butyrolactone, tetrahydrofuran and derivatives thereof
10/15/2003EP1351667A1 Pharmaceutical composition containing citalopram
10/15/2003EP0946565B1 Method and device for production of lyophilized hydrochloride-1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
10/15/2003EP0916651B1 Phenylalkylcarboxylic acid derivatives
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1448420A Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same
10/15/2003CN1124249C Method for preparing oxy-diphthalic anhydrides
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632788 For use as fragrance chemicals
10/14/2003CA2162128C Quaternary ammonium and waterproofing/preservative compositions
10/09/2003WO2003082890A1 Diastereoselective process for preparing of beta-d and beta-l 2' , 3' -dideoxy nucleoside analogs
10/09/2003WO2003082861A2 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003WO2003082847A1 Benzofuran derivative
10/09/2003WO2003082791A1 Liquid phase oxidation of halogenated ortho-xylenes
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082264A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003082192A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003US20030191340 Catalytic compositions and methods for asymmetric allylic alkylation
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191306 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191014 Preparation of new layered double hydroxides exchanged with diisopropylamide for C-C bond forming reactions
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003CA2480054A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2381341A1 Process and intermediates for preparing escitalopram
10/08/2003EP1349846A1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
10/08/2003EP1349845A1 Method for the hydrogenation of maleic anhydride and related compounds in a fluid bed reactor
10/08/2003EP1349844A1 Method for the hydrogenation of maleic anhydride and related compounds in two serial reaction zones
10/08/2003EP1349822A1 Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures
10/08/2003EP1349613A2 Thrombopoietin mimetics
10/08/2003EP1349548A2 Methods and compositions for treating periodontal disease
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP0966245B1 Antimicrobial cosmetic compositions
10/08/2003EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003EP0626967B1 Process for preparing enantiomerically pure fluorinated epoxychromans
10/08/2003CN1447803A Hyperpolarizable organic chromophores
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447786A Two-stage process for hydrogenation of maleic acid to 1,4-butanediol
10/08/2003CN1447785A Method for vapour-phase partial oxidation aromatic hydrocarbons
10/08/2003CN1446809A Derivant of new type sweetsop lactone as well as preparation method and usage
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/02/2003WO2003080590A1 Process for the isolation of high purity crystalline citalopram base
10/02/2003WO2003080589A1 Purified citalopram salts
10/02/2003WO2003080588A1 Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080559A1 Oligofluorenylene compounds
10/02/2003WO2003080553A1 Cyclopentene derivatives
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003039529A8 Selective antibacterial agents
10/02/2003WO2002094760A3 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003US20030187280 (Per) haloethers
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 472